1. Home
  2. UNCY vs SWVL Comparison

UNCY vs SWVL Comparison

Compare UNCY & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • SWVL
  • Stock Information
  • Founded
  • UNCY 2016
  • SWVL 2017
  • Country
  • UNCY United States
  • SWVL United Arab Emirates
  • Employees
  • UNCY N/A
  • SWVL N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • SWVL Business Services
  • Sector
  • UNCY Health Care
  • SWVL Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • SWVL Nasdaq
  • Market Cap
  • UNCY 31.9M
  • SWVL 32.2M
  • IPO Year
  • UNCY 2021
  • SWVL N/A
  • Fundamental
  • Price
  • UNCY $0.46
  • SWVL $4.79
  • Analyst Decision
  • UNCY Strong Buy
  • SWVL
  • Analyst Count
  • UNCY 4
  • SWVL 0
  • Target Price
  • UNCY $5.50
  • SWVL N/A
  • AVG Volume (30 Days)
  • UNCY 1.9M
  • SWVL 47.3K
  • Earning Date
  • UNCY 11-13-2024
  • SWVL 12-26-2024
  • Dividend Yield
  • UNCY N/A
  • SWVL N/A
  • EPS Growth
  • UNCY N/A
  • SWVL N/A
  • EPS
  • UNCY N/A
  • SWVL 0.27
  • Revenue
  • UNCY N/A
  • SWVL $22,852,263.00
  • Revenue This Year
  • UNCY N/A
  • SWVL $1,728.00
  • Revenue Next Year
  • UNCY N/A
  • SWVL N/A
  • P/E Ratio
  • UNCY N/A
  • SWVL $12.95
  • Revenue Growth
  • UNCY N/A
  • SWVL N/A
  • 52 Week Low
  • UNCY $0.20
  • SWVL $0.85
  • 52 Week High
  • UNCY $1.82
  • SWVL $21.94
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 48.64
  • SWVL 72.51
  • Support Level
  • UNCY $0.41
  • SWVL $3.57
  • Resistance Level
  • UNCY $0.55
  • SWVL $3.93
  • Average True Range (ATR)
  • UNCY 0.06
  • SWVL 0.40
  • MACD
  • UNCY -0.01
  • SWVL 0.12
  • Stochastic Oscillator
  • UNCY 23.47
  • SWVL 62.21

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About SWVL Swvl Holdings Corp

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.

Share on Social Networks: